Skip to Content
Endocrine and Breast Oncology SurgeonAssistant Professor of Surgery - Surgical Oncology and Endocrine Surgery
Primary Office: 4641 JCPIowa City, IA 52242 Primary Office Phone: 319-356-1327
Email: geeta-lal@uiowa.edu
BS, Summa cum Laude, McMaster University, Ontario, CanadaMD, Honors, University of Toronto, Ontario, CanadaMSc, University of Toronto and The Samuel Lunenfeld Research Institute, Ontario, Canada
Residency, General Surgery, University of Toronto, Ontario, CanadaFellowship, Endocrine Surgical Oncology, Mt. Zion Medical Center, University of California, San Francisco
Iowa Board of Medical Examiners College of Physicians & Surgeons of Ontario (independent practice)Board Certified, American Board of Surgery Specialist Certification - General Surgery, Royal College of Physicians and Surgeons, CanadaClinician Investor Program, Royal College of Physicians and Surgeons, Canada
My lab is interested in studying genetic markers that can be used for diagnosis and in predicting prognosis of thyroid cancer and other endocrine malignancies. We also maintain an endocrine tumor tissue bank. We are also involved in several clinical projects in endocrine surgical oncology.
Show All
Risk of second primary thyroid cancer following another malignancy: Trends in a population-based study. Lal G, Groff M, Howe J, Weigel , Sugg S, Lynch C. Ann Surg Oncol . 2012 January (1st Quarter/Winter). Incidental finding of Composite pheochromocytoma-ganglioneuroma: Successful management after emergent appendectomy and review of the literature.. Lal G, Weigel R, Kirby P, Miron , Royer N. World Journal of Endocrine surgery . 2011; 3 (1) :34-44. Parathyroid cancer. Lal G, Fang S. Endocr Pract. 2011; 1 :36-43. Surveillance and intervention following thyroid lobectomy. Lal G, Spanheimer P, Sugg S, Howe J, Weigel R. Ann Surg Oncol . 2011; 18 (6) :1729-33. . Lal G, Clark O. 2010 December. Management of Differentiated Thyroid cancers – Updated guidelines from the American Thyroid Association.Basic and Clinical Endocrinology . Lal G, Gardner D, Greenspan F, Clark O. 8. McGraw-Hill Companies; 2010. Endocrine Surgery.Expansion of a cell population expressing Stem cell markers in parathyroid glands from patients with Hyperparathyroidism. Lal G, Weigel , Fang S, Guidroz J, O’Malley , Sugg , Howe J. Ann Surg. 2010; 251 (1) :107-13. PET-CT for recurrent or persistent differentiated thyroid cancer – Is there added utility beyond conventional imaging? . Lal G, Fairchild , Howe J, Weigel R, Sugg S, Menda Y. Surgery. 2010; 148 (6) :1082-9. Determinants of survival in patients with calciphylaxis – a multivariate analysis. Lal G, Nowell A, Liao J, Sugg , Weigel R, Howe J. Surgery. 2009; 146 (6) :1028-34. Extracellular Matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer – a hospital-based cohort study in Iowa. Lal G, Hashimi , Smith B, Zhang L, Lynch , Robinson R, Weigel . Ann Surg Oncol . 2009; 16 (8) :2280-7.
Date Last Modified: 01/08/2013 - 17:05:00